Paolo Tarantino, Research Fellow Dana-Farber Cancer Institute and Harvard Medical School, shared a post on LinkedIn:
“Looking forward to joining Ruta Rao, Jame Abraham, and Kamel Abou Hussein for ‘Hot Seat: Which Agent, and When?‘ at ASCO26, discussing next-generation endocrine strategies in HR+/HER2– breast cancer.
May 31, 6:30–8:00 PM CDT
Sheraton Grand Chicago Riverwalk
Dato-DXd Plus Durvalumab Shows Durable First-Line Activity in Advanced TNBC
